- Home
- OBIO vs PINE Comparison
OBIO vs PINE Comparison
Compare OBIO & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PINE
- Stock Information
- Founded
- OBIO 2017
- PINE 2019
- Country
- OBIO United States
- PINE United States
- Employees
- OBIO N/A
- PINE N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PINE Real Estate Investment Trusts
- Sector
- OBIO Health Care
- PINE Real Estate
- Exchange
- OBIO Nasdaq
- PINE Nasdaq
- Market Cap
- OBIO 200.1M
- PINE 239.5M
- IPO Year
- OBIO N/A
- PINE 2019
- Fundamental
- Price
- OBIO $4.88
- PINE $17.21
- Analyst Decision
- OBIO Strong Buy
- PINE Strong Buy
- Analyst Count
- OBIO 4
- PINE 9
- Target Price
- OBIO $15.75
- PINE $19.39
- AVG Volume (30 Days)
- OBIO 53.8K
- PINE 93.6K
- Earning Date
- OBIO 11-12-2024
- PINE 02-06-2025
- Dividend Yield
- OBIO N/A
- PINE 6.43%
- EPS Growth
- OBIO N/A
- PINE N/A
- EPS
- OBIO N/A
- PINE 0.23
- Revenue
- OBIO $2,647,000.00
- PINE $50,017,000.00
- Revenue This Year
- OBIO $12.39
- PINE N/A
- Revenue Next Year
- OBIO $120.99
- PINE $6.76
- P/E Ratio
- OBIO N/A
- PINE $75.37
- Revenue Growth
- OBIO N/A
- PINE 9.55
- 52 Week Low
- OBIO $4.22
- PINE $14.33
- 52 Week High
- OBIO $10.46
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- OBIO 43.91
- PINE 39.08
- Support Level
- OBIO $4.78
- PINE $17.04
- Resistance Level
- OBIO $5.84
- PINE $17.37
- Average True Range (ATR)
- OBIO 0.42
- PINE 0.28
- MACD
- OBIO -0.04
- PINE -0.06
- Stochastic Oscillator
- OBIO 24.24
- PINE 17.82
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate company. It owns and operates a portfolio of single-tenant commercial properties. The company's portfolio is comprised of single-tenant retail and office properties located in or in close proximity to MSAs, growth markets and other markets in the United States. Their portfolio consists of One thirty eight net leased properties located in Hundred and four markets in thirty five states. The majority of the firm's revenue includes rental revenue derived from the ownership and leasing of property.